Andreas Seidl
Chief Tech/Sci/R&D Officer at FORMYCON AG
Profile
Andreas Seidl is currently the Chief Operating Officer at LEUKOCARE AG and the Chief Scientific Officer at Formycon AG.
He holds a doctorate degree from Universität Konstanz.
Andreas Seidl active positions
| Companies | Position | Start |
|---|---|---|
| FORMYCON AG | Chief Tech/Sci/R&D Officer | 2022-06-30 |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Chief Operating Officer | 2019-03-31 |
Training of Andreas Seidl
| Universität Konstanz | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Private companies | 1 |
|---|---|
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Health Services |
- Stock Market
- Insiders
- Andreas Seidl